domingo, 11 de diciembre de 2011

Hepatitis E Virus Antibodies in Blood Donors, France - Vol. 17 No. 12 - December 2011 - Emerging Infectious Disease journal - CDC

Volume 17, Number 12—December 2011


Hepatitis E Virus Antibodies in Blood Donors, France

Jean-Michel Mansuy, Richard Bendall, Florence Legrand-Abravanel, Karine Sauné, Marcel Miédouge, Vic Ellis, Henri Rech, François Destruel, Nassim Kamar, Harry R. Dalton, and Jacques IzopetComments to Author 
Author affiliations: Hôpital Purpan, Toulouse, France (J.-M. Mansuy, F. Legrand-Abravanel, K. Sauné, M. Miédouge, J. Izopet); Royal Cornwall Hospital Trust, Truro, UK (R. Bendall, V. Ellis, H.R. Dalton); Institut National de la Santé et de la Recherche Médicale, Toulouse (F. Legrand-Abravanel, K. Sauné, N. Kamar, J. Izopet); Université Toulouse III Paul Sabatier, Toulouse (K. Sauné, N. Kamar, J. Izopet); Etablissement Français du Sang Pyrénées-Méditerranée, Toulouse (H. Rech, F. Destruel); Peninsula College of Medicine and Dentistry, Truro (H.R. Dalton); Hôpital Rangueil, Toulouse (N. Kamar)
Suggested citation for this article


Using a validated sensitive assay, we found hepatitis E virus (HEV) IgG in 52.5% of voluntary blood donors in southwestern France. This finding suggests HEV is highly endemic to this region. The high HEV prevalence may reflect local dietary practices, such as eating uncooked pork and game products.
It is now recognized that hepatitis E virus infection is not confined to developing countries. HEV infection is a growing public health concern in industrialized countries where the disease is mainly autochthonous, caused by HEV genotypes 3 (Europe) and 4 (People’s Republic of China and Japan), and is thought to be zoonotic (1).

In a previous study, we estimated that 16.6% of blood donors in the Midi-Pyrénées region of southwestern France have HEV antibodies (2). This rate was much higher than that measured in northern France (3), which suggests differences between these 2 populations and their exposure to HEV that we wished to explore further. However, it is difficult to make wider comparisons with seroprevalence studies from other areas because the various assays used differed in sensitivity and specificity (4). Because a recent study suggested that the HEV IgG assay we used in our original study lacks sensitivity (5), we repeated and extended the study using a more sensitive assay that has been validated by using serum from PCR-proven HEV genotype 3 infections (5).

Hepatitis E Virus Antibodies in Blood Donors, France - Vol. 17 No. 12 - December 2011 - Emerging Infectious Disease journal - CDC

Suggested citation for this article: Mansuy J-M, Bendall R, Legrand-Abravanel F, Sauné K, Miédouge M, Ellis V, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis [serial on the Internet]. 2011 Dec [date cited]. Web Site Icon
DOI: 10.3201/eid1712.110371

No hay comentarios:

Publicar un comentario